2025 annual financial data
Whitehawk Therapeutics 2025 Operating margin
Direct answer
Operating margin was -1,601.12%.
Operating income was -114,400,000 USD and net income was -20,596,000 USD.
Operating cash flow was -97,433,000 USD.
Get free Whitehawk Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,145,000 USD
- Operating income
- -114,400,000 USD
- Net income
- -20,596,000 USD
- Operating cash flow
- -97,433,000 USD